Out of 10 antibodies discovered, one gave strong protection against EBV in mice with humanlike immune systems (pretty promising for real-world use).
This breakthrough is especially big news for organ transplant patients, who face extra risks from EBV complications.
The next step: moving these findings into human safety trials, bringing hope for fewer long-term health problems tied to this stubborn virus.